Literature DB >> 27366933

Comparison between the TRS-398 code of practice and the TG-51 dosimetry protocol for flattening filter free beams.

J E Lye1, D J Butler, C P Oliver, A Alves, J Lehmann, F P Gibbons, I M Williams.   

Abstract

Dosimetry protocols for external beam radiotherapy currently in use, such as the IAEA TRS-398 and AAPM TG-51, were written for conventional linear accelerators. In these accelerators, a flattening filter is used to produce a beam which is uniform at water depths where the ionization chamber is used to measure the absorbed dose. Recently, clinical linacs have been implemented without the flattening filter, and published theoretical analysis suggested that with these beams a dosimetric error of order 0.6% could be expected for IAEA TRS-398, because the TPR20,10 beam quality index does not accurately predict the stopping power ratio (water to air) for the softer flattening-filter-free (FFF) beam spectra. We measured doses on eleven FFF linacs at 6 MV and 10 MV using both dosimetry protocols and found average differences of 0.2% or less. The expected shift due to stopping powers was not observed. We present Monte Carlo k Q calculations which show a much smaller difference between FFF and flattened beams than originally predicted. These results are explained by the inclusion of the added backscatter plates and build-up filters used in modern clinical FFF linacs, compared to a Monte Carlo model of an FFF linac in which the flattening filter is removed and no additional build-up or backscatter plate is added.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27366933     DOI: 10.1088/0031-9155/61/14/N362

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  1 in total

1.  A comparison of IROC and ACDS on-site audits of reference and non-reference dosimetry.

Authors:  Jessica Lye; Stephen Kry; Maddison Shaw; Francis Gibbons; Stephanie Keehan; Joerg Lehmann; Tomas Kron; David Followill; Ivan Williams
Journal:  Med Phys       Date:  2019-10-25       Impact factor: 4.071

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.